Trials / Completed
CompletedNCT00772369
Retrospective Survey of Safety of Fourth Dose Pentacel® in Children
Retrospective Safety Survey of Selected Events in the 6 Months Following the 4th Dose of the Pentacel® Vaccination Series in Children
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,214 (actual)
- Sponsor
- Sanofi Pasteur, a Sanofi Company · Industry
- Sex
- All
- Age
- 12 Months – 24 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this survey is to collect selected safety data. Primary Objective: To collect selected safety data at 6 months following the 4th dose of the Pentacel® series.
Detailed description
This is a retrospective survey to collect selected safety data at 6 months following the 4th dose of Pentacel® in children residing in the Canadian Province of British Columbia who have received the 4th dose of the Pentacel® series before their 2nd birthday.
Conditions
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2004-04-01
- Completion
- 2005-04-01
- First posted
- 2008-10-15
- Last updated
- 2014-02-14
- Results posted
- 2010-04-02
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00772369. Inclusion in this directory is not an endorsement.